Publication | Open Access
PAM50 breast cancer intrinsic subtypes and effect of gemcitabine in advanced breast cancer patients
32
Citations
22
References
2013
Year
A significantly improved and clinically important prolongation of survival was seen from the addition of gemcitabine to docetaxel in advanced basal-like breast cancer patients.
| Year | Citations | |
|---|---|---|
Page 1
Page 1